William  Hoffman net worth and biography

William Hoffman Biography and Net Worth

Bill has focused on early stage companies with novel devices in new markets. Prior to Inari Medical, Bill served as CEO of Visualase, Inc., which developed and sold lasers for minimally invasive neurosurgery. The company was acquired by Medtronic for $105M in July, 2014, having raised less than $10m in equity funding. Prior to Visualase, Bill was Vice President of Sales at FoxHollow, Inc., helping to build a commercial team and revenue ramp that led to a successful IPO in 2004 and an acquisition by EV3 in 2007. Bill’s first early stage med tech experience was as head of sales at RITA Medical Systems, an interventional oncology company that enjoyed a successful IPO in 2000. He spent the early part of his career in various sales roles at Ethicon and Medtronic.

What is William Hoffman's net worth?

The estimated net worth of William Hoffman is at least $21.96 million as of December 16th, 2024. Mr. Hoffman owns 441,233 shares of Inari Medical stock worth more than $21,960,166 as of January 5th. This net worth estimate does not reflect any other investments that Mr. Hoffman may own. Learn More about William Hoffman's net worth.

How do I contact William Hoffman?

The corporate mailing address for Mr. Hoffman and other Inari Medical executives is 9 Parker Suite 100, Irvine CA, 92618. Inari Medical can also be reached via phone at 877-923-4747 and via email at ir@inarimedical.com. Learn More on William Hoffman's contact information.

Has William Hoffman been buying or selling shares of Inari Medical?

William Hoffman has not been actively trading shares of Inari Medical during the past quarter. Most recently, William Hoffman sold 60,000 shares of the business's stock in a transaction on Monday, December 16th. The shares were sold at an average price of $55.66, for a transaction totalling $3,339,600.00. Following the completion of the sale, the director now directly owns 441,233 shares of the company's stock, valued at $24,559,028.78. Learn More on William Hoffman's trading history.

Who are Inari Medical's active insiders?

Inari Medical's insider roster includes Rebecca Chambers (Director), Mitch Hill (CFO), William Hoffman (CEO), Andrew Hykes (CEO, President & Director), Donald Milder (Director), Kirk Nielsen (Director), and Thomas Tu (Insider). Learn More on Inari Medical's active insiders.

Are insiders buying or selling shares of Inari Medical?

In the last year, insiders at the sold shares 26 times. They sold a total of 562,744 shares worth more than $27,798,968.16. The most recent insider tranaction occured on December, 20th when CEO Andrew Hykes sold 3,000 shares worth more than $165,870.00. Insiders at Inari Medical own 10.6% of the company. Learn More about insider trades at Inari Medical.

Information on this page was last updated on 12/20/2024.

William Hoffman Insider Trading History at Inari Medical

William Hoffman Buying and Selling Activity at Inari Medical

This chart shows William Hoffman's buying and selling at Inari Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$10M-$5M$0$5M$10MTotal Insider BuyingTotal Insider Selling

Inari Medical Company Overview

Inari Medical logo
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Read More

Today's Range

Now: $49.77
Low: $48.87
High: $53.31

50 Day Range

MA: $51.80
Low: $42.56
High: $58.21

2 Week Range

Now: $49.77
Low: $36.73
High: $65.94

Volume

1,311,194 shs

Average Volume

1,093,997 shs

Market Capitalization

$2.91 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.97